ODDB.org: Open Drug Database

XGEVA 120 mg, Injektionslösung - Durchstechflasche(n)

Swissmedic Key	61865001	Registration Holder	Amgen Switzerland AG
Name	XGEVA 120 mg, Injektionslösung	Date of registration	02.12.2011
		Introduction of Sequence	02.12.2011
ATC-Classification	Denosumab (M05BX04)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	07.16.10.	Show package size	Durchstechflasche(n)
Index Therapeuticus (Swissmedic)	07.16.10.	Description
Swissmedic categorie.	A
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	379.81	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	429.50
Feedback	FB	Daily cost
GTIN	7680618650014	Medication Code	Biotechnologika
Pharmacode	5106068	Disponibility

Composition

denosumabum 120 mg, sorbitolum 78.1 mg, polysorbatum 20, acidum aceticum glaciale aut natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1.7 ml corresp. natrium 0.7 mg.

Packungsbestandteile

Galenic Form

Injection solution

Excipiens

Active Agent	Dose
Denosumabum	120mg / 1.7ml

BAG: Active Agent	Dose
Denosumabum	120 mg

Inactive agents	Dose
Acidum Aceticum Glaciale aut Natrii Hydroxidum
Polysorbatum 20
Sorbitol	78.1mg / 1.7ml

Source

Data was imported : 06.04.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH